Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. UHS
UHS logo

UHS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Universal Health Services Inc (UHS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
168.230
1 Day change
-1.02%
52 Week Range
246.320
Analysis Updated At
2026/04/24
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Universal Health Services Inc. (UHS) is not a strong buy at this moment for a beginner investor with a long-term strategy. While the company has shown strong financial performance in its latest quarter, the technical indicators and trading sentiment do not currently support a compelling entry point. The stock is in a pre-market decline, and there are no significant positive catalysts or trading signals to indicate an immediate buying opportunity.

Technical Analysis

The MACD is positive and expanding, suggesting bullish momentum. However, the RSI is neutral at 50.35, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 177.694), but the overall technical picture does not strongly support a buy.

Options Data

Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
10
Buy
2

Positive Catalysts

  • Strong financial performance in Q4 2025, with revenue up 9.05% YoY, net income up 34.16% YoY, and EPS up 42.34% YoY.

Neutral/Negative Catalysts

  • Pre-market price decline of -1.85%. Analysts have recently lowered price targets, citing weak acute business results and above-average exposure to policy changes. No recent news or significant trading trends from hedge funds or insiders.

Financial Performance

In Q4 2025, the company reported revenue of $4.49 billion (+9.05% YoY), net income of $445.94 million (+34.16% YoY), and EPS of $7.06 (+42.34% YoY). Gross margin remained stable at 100%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts' ratings are mixed. While some maintain a Buy rating with price targets as high as $320, others have lowered their targets, citing weak acute business performance and policy exposure. The average sentiment leans towards cautious optimism but lacks strong consensus for a buy.

Wall Street analysts forecast UHS stock price to rise
15 Analyst Rating
Wall Street analysts forecast UHS stock price to rise
7 Buy
7 Hold
1 Sell
Moderate Buy
Current: 169.960
sliders
Low
190
Averages
248
High
302
Current: 169.960
sliders
Low
190
Averages
248
High
302
UBS
Buy
to
Buy
downgrade
$320 -> $310
AI Analysis
2026-04-30
Reason
UBS
Price Target
$320 -> $310
AI Analysis
2026-04-30
downgrade
Buy
to
Buy
Reason
UBS lowered the firm's price target on Universal Health to $310 from $320 and keeps a Buy rating on the shares.
TD Cowen
Buy
downgrade
$245 -> $230
2026-04-29
Reason
TD Cowen
Price Target
$245 -> $230
2026-04-29
downgrade
Buy
Reason
TD Cowen lowered the firm's price target on Universal Health to $230 from $245 and keeps a Buy rating on the shares. The firm updated its model following Q1 results. They recognize investor caution but believes the reaction is overdone.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for UHS
Unlock Now

People Also Watch